ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

23 links0 made here, not in the record17 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03277924Trial of Sunitinib and/orNivolumab Plus Chemotherapyin Advanced Soft Tissue andBone SarcomasGrupo Espanol de InvestigacionPhase 1/Phase 2 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSSarcomaThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionBone NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Chondrosarcoma, Extraskelet…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.HemangiosarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.HemangioendotheliomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Solitary Fibrous TumorsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Sarcoma, Clear CellThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Sarcoma, Alveolar Soft PartThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Histiocytoma, Malignant Fib…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.LeiomyosarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.OsteosarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Sarcoma, SynovialThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Hemangioendothelioma, Epith…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Sarcoma, EwingThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.ChondrosarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSSunitinibEntry “Sunitinib 37.5 MG, Sunitinib 2…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundNivolumabEntry “Nivolumab 100 MG/10 ML [Opdivo…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedEpirubicinIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundIfosfamideIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundDoxorubicinIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundDacarbazineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCisplatinIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundMethotrexateIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Sunitinib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background
Background · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2SunitinibClaude Opus 5.5BackgroundCurrent
Nov 2NivolumabClaude Opus 5.5TestedCurrent
Nov 2EpirubicinClaude Opus 5.5BackgroundCurrent
Nov 2IfosfamideClaude Opus 5.5BackgroundCurrent
Nov 2DoxorubicinClaude Opus 5.5BackgroundCurrent
Nov 2DacarbazineClaude Opus 5.5BackgroundCurrent
Nov 2CisplatinClaude Opus 5.5BackgroundCurrent
Nov 2MethotrexateClaude Opus 5.5BackgroundCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 18SunitinibRule based · role ruleBackgroundAgrees
Nov 18NivolumabRule based · role ruleTestedAgrees
Nov 18EpirubicinRule based · role ruleBackgroundAgrees
Nov 18IfosfamideRule based · role ruleBackgroundAgrees
Nov 18DoxorubicinRule based · role ruleBackgroundAgrees
Nov 18DacarbazineRule based · role ruleBackgroundAgrees
Nov 18CisplatinRule based · role ruleBackgroundAgrees
Nov 18MethotrexateRule based · role ruleBackgroundAgrees
As of nowSarcomaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.